Fuse Medical Inc(FZMD)
USD --+0.00%
Reward49Moderate
Risk54Moderate
📊75%Data
Strong 22% profit margin
FZMD
+0.0 · +0.00%
USD · PINK
Fuse Medical Inc | Healthcare
Balanced
Market Cap:2.96M
ℹ️
Reward Rating
49
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
54
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on FZMD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Fuse Medical Inc?

manufactures and distributes medical devices in the United States.

FZMD · Verdict

Moderate reward · elevated risk

FZMD's standout is volatility; cash flow and balance sheet weigh on the picture.

Based on 88% data coverage

FZMD · Verdict

What’s working & what to watch

Strengths 1

  • Volatility75/100

    Above average

Watchouts 4

  • Cash flow35/100

    -2% free-cash-flow margin

  • Balance sheet41/100

    Interest covered 3.8×

  • Growth45/100

    Revenue -19.3% CAGR

  • Profitability45/100

    5% net margin · 0% ROE

Model-based scoring. For information only — not financial advice.

What is Fuse Medical Inc?

manufactures and distributes medical devices in the United States. The company provides orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.96M, and a P/E ratio of 1.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (49)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.96M
P/E Ratio1.3333
Dividend YieldN/A
52 Week High0.1
52 Week Low0.02
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding74M
No. of EmployeesN/A
IndustryMedical Devices
ExchangePINK
Beta-1.226
CurrencyUSD